313 related articles for article (PubMed ID: 18625449)
1. Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.
Bateman RJ; Klunk WE
Neurotherapeutics; 2008 Jul; 5(3):381-90. PubMed ID: 18625449
[TBL] [Abstract][Full Text] [Related]
2. Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.
Golde TE
J Neurochem; 2016 Oct; 139 Suppl 2(Suppl 2):224-236. PubMed ID: 27145445
[TBL] [Abstract][Full Text] [Related]
3. The past, present, and future of disease-modifying therapies for Alzheimer's disease.
Suzuki K; Iwata A; Iwatsubo T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305
[TBL] [Abstract][Full Text] [Related]
4. Review on Alzheimer's disease: Inhibition of amyloid beta and tau tangle formation.
Ashrafian H; Zadeh EH; Khan RH
Int J Biol Macromol; 2021 Jan; 167():382-394. PubMed ID: 33278431
[TBL] [Abstract][Full Text] [Related]
5. Novel disease-modifying therapies for Alzheimer's disease.
Jiang T; Yu JT; Tan L
J Alzheimers Dis; 2012; 31(3):475-92. PubMed ID: 22669013
[TBL] [Abstract][Full Text] [Related]
6. Understanding the cause of sporadic Alzheimer's disease.
Zetterberg H; Mattsson N
Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227
[TBL] [Abstract][Full Text] [Related]
7. The Prion-like Properties of Amyloid-beta Peptide and Tau: Is there Any Risk of Transmitting Alzheimer's Disease During Neurosurgical Interventions?
Padilla-Zambrano HS; García-Ballestas E; Quiñones-Ossa GA; Sibaja-Perez AE; Agrawal A; Moscote-Salazar LR; Menéndez-González M
Curr Alzheimer Res; 2020; 17(9):781-789. PubMed ID: 33280597
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Review on Alzheimer's Disease: Causes and Treatment.
Breijyeh Z; Karaman R
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302541
[TBL] [Abstract][Full Text] [Related]
9. Abeta, tau and ApoE4 in Alzheimer's disease: the axonal connection.
Adalbert R; Gilley J; Coleman MP
Trends Mol Med; 2007 Apr; 13(4):135-42. PubMed ID: 17344096
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease: Unique markers for diagnosis & new treatment modalities.
Aggarwal NT; Shah RC; Bennett DA
Indian J Med Res; 2015 Oct; 142(4):369-82. PubMed ID: 26609028
[TBL] [Abstract][Full Text] [Related]
11. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease.
Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK
Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007
[TBL] [Abstract][Full Text] [Related]
12. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
Koychev I; Hofer M; Friedman N
J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
[TBL] [Abstract][Full Text] [Related]
13. Progression of Alzheimer's disease, tau propagation, and its modifiable risk factors.
Takeda S
Neurosci Res; 2019 Apr; 141():36-42. PubMed ID: 30120962
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer's Disease.
Zhao Y; Zhang Y; Zhang J; Zhang X; Yang G
Curr Neuropharmacol; 2020; 18(8):720-739. PubMed ID: 31934838
[TBL] [Abstract][Full Text] [Related]
15. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
16. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.
Barage SH; Sonawane KD
Neuropeptides; 2015 Aug; 52():1-18. PubMed ID: 26149638
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
18. Calcium signaling in Alzheimer's disease & therapies.
Tong BC; Wu AJ; Li M; Cheung KH
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1745-1760. PubMed ID: 30059692
[TBL] [Abstract][Full Text] [Related]
19. Tau therapeutics for Alzheimer's disease: the promise and the challenges.
Gold M
J Mol Neurosci; 2002 Dec; 19(3):331-4. PubMed ID: 12540060
[TBL] [Abstract][Full Text] [Related]
20. Tau-based therapeutic approaches for Alzheimer's disease - a mini-review.
Boutajangout A; Wisniewski T
Gerontology; 2014; 60(5):381-5. PubMed ID: 24732638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
